<DOC>
	<DOCNO>NCT00712257</DOCNO>
	<brief_summary>A Multicenter study evaluation safety performance Spectranetics Laser Adjunct PTA Gore Viabahn Endoprosthesis Treatment SFA Instent Restenosis</brief_summary>
	<brief_title>Study Evaluate Safety Performance Spectranetics Laser w/Adjunct PTA Gore Viabahn Endoprosthesis Treatment SFA Instent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Heparin</mesh_term>
	<criteria>Subject subject 's legal representative inform study nature . Subject understands duration study follow visit requirement . Intermittent claudication extend critical limb ischemia meeting Rutherford 25 category . Subject able walk unassisted . Female subject childbearing potential must negative serum pregnancy test 7 day prior treatment . Life expectancy le 12 month Myocardial infarction le 3 month prior procedure Known allergy sensitivities heparin , aspirin , anticoagulant/antiplatelet therapy nitinol . Known allergy contrast medium adequately premedicated prior study procedure . Uncontrolled hypercoagulability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>treatment superficial femoral artery instent restenosis</keyword>
</DOC>